Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants ...

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

Wegovy treated a serious form of liver disease in a major clinical trial The Phase 3 clinical trial found that Wegovy reduced inflammation and scarring in people with metabolic dysfunction ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...